Screening a fragment cocktail library using ultrafiltration
- 13 July 2011
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 401 (5) , 1585-1591
Abstract
Ultrafiltration provides a generic method to discover ligands for protein drug targets with millimolar to micromolar K d, the typical range of fragment-based drug discovery. This method was tailored to a 96-well format, and cocktails of fragment-sized molecules, with molecular masses between 150 and 300 Da, were screened against medical structural genomics target proteins. The validity of the method was confirmed through competitive binding assays in the presence of ligands known to bind the target proteins.Keywords
This publication has 45 references indexed in Scilit:
- Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand EfficiencyJournal of Medicinal Chemistry, 2010
- Catalysis and Inhibition of Mycobacterium tuberculosis Methionine AminopeptidaseJournal of Medicinal Chemistry, 2009
- Buffer Optimization of Thermal Melt Assays of Plasmodium Proteins for Detection of Small-Molecule LigandsSLAS Discovery, 2009
- A decade of fragment-based drug design: strategic advances and lessons learnedNature Reviews Drug Discovery, 2007
- An Ultraefficient Affinity-Based High-Throughout Screening Process: Application to Bacterial Cell Wall Biosynthesis Enzyme MurFSLAS Discovery, 2006
- Applications of mass spectrometry in early stages of target based drug discoveryJournal of Pharmaceutical and Biomedical Analysis, 2006
- Improving success rates for lead generation using affinity binding technologiesCurrent Opinion in Biotechnology, 2005
- Fragment-Based Lead Discovery Using X-ray CrystallographyJournal of Medicinal Chemistry, 2004
- Crystal Structure of Schizosaccharomyces pombe Riboflavin Kinase Reveals a Novel ATP and Riboflavin-Binding FoldJournal of Molecular Biology, 2003
- Discovering High-Affinity Ligands for Proteins: SAR by NMRScience, 1996